IDXX | Idexx LaboratoriesNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$672.04
+$0.40 (+0.06%)

Idexx Laboratories (IDXX) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.

Right now the daily is the chart to watch. The 50 SMA has sat below the 200 since Mar 2026, but the two have been closing on each other and a golden cross is projected within 20 bars. On both the daily and the 4-hour, price sits above the 50 and the 200; on the weekly it is between the two.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
above both $672.04 vs 50 $538.81 / 200 $572.20
Projection
Golden cross projected in 15 bars
Test
No active test
Last cross
Death cross 26 Mar 2026 ยท projected 21 bars out

Weekly as of 30 Oct 16:00 ET

Price
between the two $551.21 vs 50 $595.16 / 200 $523.47
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 1 Sep 2025 ยท projected 30 bars out

4-hour as of 3 Nov 16:00 ET

Price
above both $672.04 vs 50 $551.59 / 200 $549.75
Projection
No cross projected
Test
No active test
Last cross
Death cross 9 Sep 2026 ยท projected 26 bars out

Cross history

34
crosses on record since 2017
16 golden18 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
9 Sep 2026Death4-hour26 bars outโ€”
6 Aug 2026Golden4-hour6 bars out1 bar cross test
26 Mar 2026Death steepdaily21 bars outNot tested
13 Feb 2026Death4-hour17 bars outNot tested
week of 1 Sep 2025Golden moderateweekly30 bars outNot tested

About IDXX

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$264M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandlarge

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.